Analysts' Actions: FDX YHOO AGN CLNE MRO

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Arbor Realty Trust ( ABR) upgraded to hold at TheStreet ratings.

Allergan ( AGN) rated new Hold at Canaccord. Valuation call, based on a $101 price target.

Baxter ( BAX) rated new Outperform at BMO. $70 price target. Company has a solid pipeline and can deliver consistent, long-term growth.

A.M. Castle ( CAS) upgraded to hold at TheStreet ratings.

Clean Energy ( CLNE) rated new Hold at Keybanc. Company lacks potential near-term catalysts.

CSX ( CSX) downgraded at UBS to Neutral from Buy, UBS said. $24.50 price target. Catalyst lacking and Q3 estimates falling.

Dover ( DOV) rated new Buy at Capstone. $71 price target. Company is focused on targeted growth areas.

FMC ( FMC) rated new Neutral at Goldman. Valuation call, based on a $62 price target.

Corning ( GLW) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $16 price target. LCD glass cycle appears to be bottoming and the company is cutting back on capital spending.

Hasbro ( HAS) downgraded at Needham from Buy to Hold, Needham said. Valuation call.

Kansas City Southern ( KSU) downgraded at UBS to Sell from Neutral, UBS said. $74 price target. Lack of catalyst and trades at premium to peers.

Lam Research ( LRCX) downgraded at Citigroup to Neutral from Buy, Citigroup said. $34 price target. Apple's shift to TSMC from Samsung could be negative.

Marathon Oil ( MRO) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $37 price target. Estimates also boosted, as the Paloma acquisition should add to earnings.

Norfolk Southern ( NSC) downgraded at UBS to Neutral from Buy, UBS said. $79 price target. Valuation trap lacking compelling investment case.

Northern Trust ( NTRS) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based $40 price target.

Charles Schwab ( SCHW) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company is leveraged to lower RMBS yields. $14 price target.

St. Jude ( STJ) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. ICD market is stabilizing and the company should benefit from a weaker dollar.

Union Pacific ( UNP) downgraded at UBS to Neutral from Buy, UBS said. $135 price target. Premium valuation moves us to sidelines.

Waste Management ( WM) downgraded at JP Morgan from Neutral to Underweight, JP Morgan said. Commodity price headwinds could weigh on near-term growth potential.

STOCK COMMENTS / EPS CHANGES

Abbott ( ABT) numbers raised at Jefferies. Shares of ABT now seen reaching $85, Jefferies said. Estimates also raised on AbbVie separation. Buy rating.

Alpha Natural ( ANR) numbers cut at UBS.Shares of ANR now seen reaching $15, UBS said. Estimates also lowered following production cut. Buy rating.

Cognizant Technology ( CTSH) target raised at Jefferies. Shares of CTSH now seen reaching $80, Jefferies said. Top- line CAGR could be 20%. Buy rating.

FedEx ( FDX) numbers lowered at Jefferies. Shares of FDX now seen reaching $93, Jefferies said. Estimates also lowered on lowered forward guidance. Hold rating.

FedEx estimates, target cut at Dahlman. Shares of FDX now seen reaching $98, according to Dahlman Rose. Estimates also reduced, given the company's new guidance. Buy rating.

McGraw-Hill ( MHP) numbers boosted at Benchmark. Shares of MHP now seen reaching $64, according to Benchmark. Estimates also upped, given the recent increase in bond issuance rates. Buy rating.

Monsanto ( MON) added to Conviction Buy List at Goldman. Estimates also upped, as rising soft commodity prices should boost demand. New $100 price target.

Transocean ( RIG) numbers lowered at Jefferies. Shares of RIG now seen reaching $57, Jefferies said. Estimates also lowered on rig sale/newbuild terms diluted. Buy rating.

Western Digital ( WDC) numbers upped at ThinkEquity. WDC estimates were boosted through 2014, ThinkEquity said. Company is keeping a tight lid on costs. Hold rating and new $44 price target.

Yahoo! ( YHOO) estimates increased at ThinkEquity through 2013, ThinkEquity said. Alibaba sale should add to earnings. Hold rating and $17 price target.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

12 Stocks That Make Up the GLUM Index

12 Stocks That Make Up the GLUM Index

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Worth a Stunning $6.6 Trillion, Tech Stocks Have Taken Over the Market

Worth a Stunning $6.6 Trillion, Tech Stocks Have Taken Over the Market

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Here's Why Snap Shares Climbed Monday

Here's Why Snap Shares Climbed Monday